side effects of going off glp 1 GLP-1 Effects: A Complete Guide to What You Can Expect Long Term GLP-1 Use: Maintenance

Seek out vendors who offer third-party testing from trusted labs, transparent batch numbers, and traceable manufacturing locations

Retatrutide: A Promising Option for Non-Diabetic Weight Loss in Clinical Trials Key Takeaways Retatrutide, a new triple receptor agonist, appears particularly promising as a non-diabetic weight loss agent because it targets glucagon, GLP-1, and GIP

Retatrutide is not yet approved by Health Canada for clinical use

The FDA wants to see actual resolution of liver inflammation and fibrosis improvement, not just fat reduction

One thing is that, in trials, some of these new medications are increasing the amount of weight loss, but that means higher reward, higher risk, with more side effects, says John Morton, MD, MPH, chief of Yale Medicine Bariatric and Minimally Invasive Surgery and a board-certified obesity medicine specialist